The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
KEYNOTE-365 cohort B: Pembrolizumab (pembro) plus docetaxel and prednisone in abiraterone (abi) or enzalutamide (enza)–pretreated patients with metastatic castration-resistant prostate cancer (mCRPC)—New data after an additional 1 year of follow-up.
 
Leonard Joseph Appleman
No Relationships to Disclose
 
Michael Paul Kolinsky
No Relationships to Disclose
 
William R. Berry
No Relationships to Disclose
 
Margitta Retz
No Relationships to Disclose
 
Loic Mourey
No Relationships to Disclose
 
Josep M. Piulats
No Relationships to Disclose
 
Emanuela Romano
No Relationships to Disclose
 
Gwenaelle Gravis
No Relationships to Disclose
 
Howard Gurney
No Relationships to Disclose
 
Johann S. De Bono
No Relationships to Disclose
 
Martin Boegemann
No Relationships to Disclose
 
Urban Emmenegger
No Relationships to Disclose
 
Anthony M. Joshua
No Relationships to Disclose
 
Christophe Massard
No Relationships to Disclose
 
Srikala S. Sridhar
No Relationships to Disclose
 
Henry Jacob Conter
No Relationships to Disclose
 
Xin Tong Li
No Relationships to Disclose
 
Charles Schloss
No Relationships to Disclose
 
Christian Heinrich Poehlein
No Relationships to Disclose
 
Evan Y. Yu
No Relationships to Disclose